Detalles de la búsqueda
1.
Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties.
Molecules
; 27(4)2022 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35209087
2.
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors.
Eur J Med Chem
; 255: 115352, 2023 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37178666
3.
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders.
J Med Chem
; 65(6): 5004-5028, 2022 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35257581
4.
Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder.
ACS Chem Neurosci
; 12(8): 1313-1327, 2021 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792287
5.
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease.
Mol Neurobiol
; 58(12): 6203-6221, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34468933
6.
G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives.
Mini Rev Med Chem
; 20(20): 2090-2103, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682373
7.
Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists.
Medchemcomm
; 10(12): 2078-2088, 2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32206242
Resultados
1 -
7
de 7
1
Próxima >
>>